IL144896A0 - Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds - Google Patents

Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds

Info

Publication number
IL144896A0
IL144896A0 IL14489600A IL14489600A IL144896A0 IL 144896 A0 IL144896 A0 IL 144896A0 IL 14489600 A IL14489600 A IL 14489600A IL 14489600 A IL14489600 A IL 14489600A IL 144896 A0 IL144896 A0 IL 144896A0
Authority
IL
Israel
Prior art keywords
several
pharmaceutical compositions
new compounds
benzaldehyde derivatives
benzaldehyde
Prior art date
Application number
IL14489600A
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of IL144896A0 publication Critical patent/IL144896A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14489600A 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds IL144896A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives
PCT/NO2000/000060 WO2000048610A1 (en) 1999-02-19 2000-02-18 Chemical compounds

Publications (1)

Publication Number Publication Date
IL144896A0 true IL144896A0 (en) 2002-06-30

Family

ID=19902986

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14489600A IL144896A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
IL14489500A IL144895A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL14489500A IL144895A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds

Country Status (15)

Country Link
EP (2) EP1150690A1 (en)
JP (2) JP2002537264A (en)
CN (2) CN1347323A (en)
AU (2) AU2834100A (en)
BR (2) BR0008297A (en)
CA (2) CA2362306A1 (en)
CZ (2) CZ20012966A3 (en)
HU (2) HUP0105281A2 (en)
IL (2) IL144896A0 (en)
MX (2) MXPA01008346A (en)
NO (1) NO309305B1 (en)
PL (2) PL350519A1 (en)
RU (2) RU2001123035A (en)
SK (2) SK11612001A3 (en)
WO (2) WO2000048609A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096921A1 (en) * 2001-05-30 2002-12-05 Nisshin Seifun Group Inc. Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine
DE10261807A1 (en) * 2002-12-19 2004-07-01 Turicum Drug Development Ag Deuterated catecholamine derivatives and medicinal products containing these compounds
CA2615678C (en) * 2005-07-26 2015-01-20 Nycomed Gmbh Isotopically substituted pantoprazole
BRPI0614039A2 (en) * 2005-07-26 2011-03-09 Nycomed Gmbh isotopically substituted proton pump inhibitors
BRPI0617987A2 (en) * 2005-10-06 2011-08-16 Auspex Pharmaceuticals Inc composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion
CN101157711B (en) * 2007-09-28 2010-12-08 西安交通大学 Compound having antineoplastic activity and uses thereof
AU2009251848A1 (en) * 2008-04-03 2009-12-03 Cognate 3, Llc Compositions and methods for immunotherapy
CN101735284B (en) * 2008-11-24 2012-05-23 上海医药工业研究院 Method for preparing 4, 6-O-benzylidene-D-glucopyranose
KR102373288B1 (en) 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. Novel methods
RU2728787C2 (en) 2014-04-04 2020-07-31 Интра-Селлулар Терапиз, Инк. Organic compounds
JP6898072B2 (en) * 2015-08-27 2021-07-07 秀行 佐谷 14-3-3 Protein activity regulator
WO2017165843A1 (en) 2016-03-25 2017-09-28 Intra-Cellular Therapies, Inc. Organic compounds
WO2018071233A1 (en) 2016-10-12 2018-04-19 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
RU2767410C2 (en) 2017-03-24 2022-03-17 Интра-Селлулар Терапиз, Инк. New compositions and methods
AU2019331490A1 (en) 2018-08-31 2021-03-18 Intra-Cellular Therapies, Inc. Novel methods
WO2020047407A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
EP4134101A1 (en) 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB811510A (en) * 1954-12-20 1959-04-08 Gyogyszeripari Ki New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof
JPS6112623A (en) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd Encephalinase inhibiting agent
JPS6256423A (en) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd Remedy and ameliorating agent for cachexia
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
JPH07145191A (en) * 1993-11-24 1995-06-06 Japan Tobacco Inc Galactosyl phosphonate derivative

Also Published As

Publication number Publication date
MXPA01008346A (en) 2003-06-06
NO990814D0 (en) 1999-02-19
CZ20012966A3 (en) 2002-03-13
WO2000048610A1 (en) 2000-08-24
MXPA01008347A (en) 2004-03-10
CA2362306A1 (en) 2000-08-24
AU2834200A (en) 2000-09-04
RU2001123035A (en) 2004-03-20
CZ20012965A3 (en) 2002-03-13
AU2834100A (en) 2000-09-04
CA2363670A1 (en) 2000-08-24
SK11602001A3 (en) 2002-02-05
HUP0105281A2 (en) 2002-05-29
EP1150689A1 (en) 2001-11-07
NO309305B1 (en) 2001-01-15
CN1347323A (en) 2002-05-01
PL350520A1 (en) 2002-12-16
RU2001123124A (en) 2004-02-20
WO2000048609A1 (en) 2000-08-24
BR0008297A (en) 2002-05-28
JP2002537264A (en) 2002-11-05
JP2002537263A (en) 2002-11-05
IL144895A0 (en) 2002-06-30
PL350519A1 (en) 2002-12-16
NO990814L (en) 2000-08-21
HUP0105280A2 (en) 2002-04-29
BR0008302A (en) 2002-08-27
SK11612001A3 (en) 2002-04-04
CN1347322A (en) 2002-05-01
EP1150690A1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
PL351387A1 (en) Pharmaceutical composition
HUP0200155A2 (en) Thioamide derivatives, pharmaceutical compositions containing them and their use
HUP0201334A3 (en) Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same
IL144895A0 (en) Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
IL137415A0 (en) Cyclobutene derivatives and pharmaceutical compositions containing the same
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0203839A3 (en) 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives, pharmaceutical compositions containing them and their use
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
GB9803521D0 (en) New compounds and pharmaceutical compositions thereof
IL156372A0 (en) Carbazole derivatives and pharmaceutical compositions containing the same
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them